|
|
For pediatric patients, intravenous fluids are the most commonly cited products involved in medication errors that are reported to the USP.
This year, an estimated 1.4 million Americans will have a new or recurrent heart attack.
After 5 years of being diagnosed with rheumatoid arthritis, one every three patients will no longer be able to work.
More than nineteen million Americans carry the factor V gene that causes blood clots, pulmonary embolism, and heart disease.
As many as 28% of hospitalized patients requiring mechanical ventilators to help them breathe (for more than 48 hours) will develop ventilator-associated pneumonia. Current therapy involves intravenous antibiotics, but new antibiotics that can be inhaled (and more directly treat the infection) are being developed.